These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 30303311

  • 1. The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers.
    Trocha M, Nowak B, Merwid-Ląd A, Szuba A, Dzięgiel P, Pieśniewska M, Gomułkiewicz A, Wiśniewski J, Piasecki T, Gziut M, Szeląg A, Sozański T.
    Adv Clin Exp Med; 2018 Nov; 27(11):1483-1490. PubMed ID: 30303311
    [Abstract] [Full Text] [Related]

  • 2. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

  • 3. Influence of ezetimibe on ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Sozański T, Ewa Chlebda-Sieragowska E, Szuba A, Dzięgiel P, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Gomułkiewicz A, Cwynar-Zając Ł, Brykner R, Szeląg A.
    Pharmacol Rep; 2013 Feb; 65(1):122-33. PubMed ID: 23563030
    [Abstract] [Full Text] [Related]

  • 4. The effect of exenatide (a GLP-1 analogue) and sitagliptin (a DPP-4 inhibitor) on asymmetric dimethylarginine (ADMA) metabolism and selected biomarkers of cardiac fibrosis in rats with fructose-induced metabolic syndrome.
    Wójcicka G, Pradiuch A, Fornal E, Stachniuk A, Korolczuk A, Marzec-Kotarska B, Nikolaichuk H, Czechowska G, Kozub A, Trzpil A, Góralczyk A, Bełtowski J.
    Biochem Pharmacol; 2023 Aug; 214():115637. PubMed ID: 37290595
    [Abstract] [Full Text] [Related]

  • 5. Sitagliptin-Dependent Differences in the Intensity of Oxidative Stress in Rat Livers Subjected to Ischemia and Reperfusion.
    Trocha M, Krzystek-Korpacka M, Merwid-Ląd A, Nowak B, Pieśniewska M, Dzięgiel P, Gomułkiewicz A, Kowalski P, Diakowska D, Szeląg A, Sozański T.
    Oxid Med Cell Longev; 2019 Aug; 2019():2738605. PubMed ID: 31781329
    [Abstract] [Full Text] [Related]

  • 6. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 7. Effect of simvastatin on nitric oxide synthases (eNOS, iNOS) and arginine and its derivatives (ADMA, SDMA) in ischemia/reperfusion injury in rat liver.
    Trocha M, Merwid-Lad A, Szuba A, Chlebda E, Pieśniewska M, Sozański T, Szelag A.
    Pharmacol Rep; 2010 Aug; 62(2):343-51. PubMed ID: 20508290
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Specific Lowering of Asymmetric Dimethylarginine by Pharmacological Dimethylarginine Dimethylaminohydrolase Improves Endothelial Function, Reduces Blood Pressure and Ischemia-Reperfusion Injury.
    Lee Y, Mehrotra P, Basile D, Ullah M, Singh A, Skill N, Younes ST, Sasser J, Shekhar A, Singh J.
    J Pharmacol Exp Ther; 2021 Feb; 376(2):181-189. PubMed ID: 33214214
    [Abstract] [Full Text] [Related]

  • 12. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans.
    Chobanyan K, Thum T, Suchy MT, Zhu B, Mitschke A, Gutzki FM, Beckmann B, Stichtenoth DO, Tsikas D.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 15; 858(1-2):32-41. PubMed ID: 17825631
    [Abstract] [Full Text] [Related]

  • 13. Changes in Biliary Levels of Arginine and its Methylated Derivatives after Hepatic Ischaemia/Reperfusion.
    Ferrigno A, Di Pasqua LG, Berardo C, Rizzo V, Richelmi P, Vairetti M.
    Basic Clin Pharmacol Toxicol; 2016 Jul 15; 119(1):101-9. PubMed ID: 26663642
    [Abstract] [Full Text] [Related]

  • 14. The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.
    Ferrigno A, Di Pasqua LG, Berardo C, Siciliano V, Rizzo V, Adorini L, Richelmi P, Vairetti M.
    PLoS One; 2018 Jul 15; 13(1):e0191430. PubMed ID: 29346429
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological activation of dimethylarginine dimethylaminohydrolase (DDAH) activity by inorganic nitrate and DDAH inhibition by NG-hydroxy-L-arginine, Nω,Nω-dimethyl-L-citrulline and Nω,Nω-dimethyl-Nδ-hydroxy-L-citrulline: results and overview.
    Bollenbach A, Tsikas D.
    Amino Acids; 2019 Mar 15; 51(3):483-494. PubMed ID: 30536052
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The L-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: biological and analytical ramifications.
    Becker T, Mevius I, de Vries DK, Schaapherder AF, zu Vilsendorf AM, Klempnauer J, Frölich JC, Tsikas D.
    Nitric Oxide; 2009 Feb 15; 20(1):61-7. PubMed ID: 18948222
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of quercetin-5'-sulfonic acid sodium salt on SOD activity and ADMA/DDAH pathway in extracorporeal liver perfusion in rats.
    Trocha M, Merwid-Lad A, Szuba A, Sozański T, Magdalan J, Szelag A, Kopacz M, Kuźniar A, Nowak D.
    Adv Clin Exp Med; 2012 Feb 15; 21(4):423-31. PubMed ID: 23240447
    [Abstract] [Full Text] [Related]

  • 20. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.
    Segarra G, Cortina B, Mauricio MD, Novella S, Lluch P, Navarrete-Navarro J, Noguera I, Medina P.
    World J Gastroenterol; 2016 Dec 28; 22(48):10545-10556. PubMed ID: 28082806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.